Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report

We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA). Patient presented to us with persistent clinically significant macular...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ashish, Madhusudhan, Rangasamy J, Nadahalli, Vidhya, Damgude, Shreekant A, Sundaramoorthy, Selva K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361827/
https://www.ncbi.nlm.nih.gov/pubmed/22569393
http://dx.doi.org/10.4103/0301-4738.95884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361827/
https://www.ncbi.nlm.nih.gov/pubmed/22569393
http://dx.doi.org/10.4103/0301-4738.95884

Ejemplares similares